[Immunological evaluation of the effectiveness of anatoxin therapy in staphylococcal infections in children].
D000367:Age Factors; D001770:Blood Bactericidal Activity; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007158:Immunologic Techniques; D007223:Infant; D007231:Infant, Newborn; D008239:Lysine / Q000097:blood; D009113:Muramidase / Q000097:blood; D010019:Osteomyelitis / Q000188:drug therapy / Q000276:immunology; D010587:Phagocytosis / Q000187:drug effects; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy / Q000276:immunology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000276:immunology*; D013208:Staphylococcal Toxoid / Q000008:administration & dosage / Q000627:therapeutic use*
D013208:Staphylococcal Toxoid; D009113:Muramidase; D008239:Lysine
Immunologicheskaia otsenka éffektivnosti anatoksinoterapii stafilokokkovykh infektsiĭ u deteĭ.